| Autor: |
Magahis PT; Weill Cornell Medical College of Cornell University, New York, New York, USA., Maron SB; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Faleck D; Gastroenterology, Hepatology, and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Laszkowska M; Gastroenterology, Hepatology, and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA laszkowm@mskcc.org. |
| Abstrakt: |
Competing Interests: Competing interests: SBM has received research funding from Guardant Health, and consulted for Basilea, Bicara, Daiichi-Sankyo, Elevation Oncology, Purple Oncology, Amgen, Novartis, and Natera. DF has received consulting fees from AzurRx, Equillium, Kaleido Biosciences, Mallinckrodt Pharmaceuticals, and OnQuality Pharmaceuticals. All other authors have no conflicts of interest to disclose. |
